Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
BMC Psychiatry
|
January 18, 2016
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
Jean Lachaine, Vanja Sikirica, Karine Mathurin
Neurology and Therapy
|
April 30, 2017
Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
Vanja Sikirica, Per A Gustafsson, Charles Makin
Orphanet Journal of Rare Diseases
|
March 13, 2024
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, et al.
Patient Preference and Adherence
|
April 13, 2016
Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
Alain Joseph, Martin Cloutier, Annie Guérin, et al.
American Journal of Obstetrics and Gynecology
|
July 7, 2009
Adhesion development and morbidity after repeat cesarean delivery
Togas Tulandi, Mohammed Agdi, Afsoon Zarei, et al.
Journal of Comparative Effectiveness Research
|
January 26, 2017
The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder
Juliana Meyers, Kavita Gajria, Sean D Candrilli, et al.
Drugs in R&D
|
November 26, 2013
Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorder
Vanja Sikirica, Moshe Fridman, Amanda Bruno, et al.
Health Economics
|
September 14, 2016
Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder
Jason Shafrin, Anshu Shrestha, Amitabh Chandra, et al.
Neuropsychiatric Disease and Treatment
|
April 15, 2017
Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
Moshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 7, 2016
Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
Peter Greven, Vanja Sikirica, Yaozhu J Chen, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
BMC Psychiatry
|
January 18, 2016
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD
Jean Lachaine, Vanja Sikirica, Karine Mathurin
Neurology and Therapy
|
April 30, 2017
Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study
Vanja Sikirica, Per A Gustafsson, Charles Makin
Orphanet Journal of Rare Diseases
|
March 13, 2024
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, et al.
Patient Preference and Adherence
|
April 13, 2016
Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
Alain Joseph, Martin Cloutier, Annie Guérin, et al.
American Journal of Obstetrics and Gynecology
|
July 7, 2009
Adhesion development and morbidity after repeat cesarean delivery
Togas Tulandi, Mohammed Agdi, Afsoon Zarei, et al.
Journal of Comparative Effectiveness Research
|
January 26, 2017
The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder
Juliana Meyers, Kavita Gajria, Sean D Candrilli, et al.
Drugs in R&D
|
November 26, 2013
Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorder
Vanja Sikirica, Moshe Fridman, Amanda Bruno, et al.
Health Economics
|
September 14, 2016
Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder
Jason Shafrin, Anshu Shrestha, Amitabh Chandra, et al.
Neuropsychiatric Disease and Treatment
|
April 15, 2017
Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey
Moshe Fridman, Tobias Banaschewski, Vanja Sikirica, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
November 7, 2016
Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
Peter Greven, Vanja Sikirica, Yaozhu J Chen, et al.
Page
of 10